HHLA2 and PD-L1 co-expression predicts poor prognosis in patients with clear cell renal cell carcinoma.
Zhou QH, Li KW, Chen X, He HX, Peng SM, Peng SR, Wang Q, Li ZA, Tao YR, Cai WL, Liu RY, Huang H.
Zhou QH, et al. Among authors: li za, li kw.
J Immunother Cancer. 2020 Jan;8(1):e000157. doi: 10.1136/jitc-2019-000157.
J Immunother Cancer. 2020.
PMID: 31959726
Free PMC article.